nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—endothelium—malaria	0.0677	0.237	CbGeAlD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—GYPA—malaria	0.0649	0.266	CbGpPWpGaD
Plerixafor—CXCR4—blood plasma—malaria	0.0601	0.21	CbGeAlD
Plerixafor—CXCR4—Binding and entry of HIV virion—CD4—malaria	0.0425	0.174	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—ABO—malaria	0.0401	0.164	CbGpPWpGaD
Plerixafor—CXCR4—hematopoietic system—malaria	0.0332	0.116	CbGeAlD
Plerixafor—CXCR4—kidney—malaria	0.0272	0.0954	CbGeAlD
Plerixafor—CXCR4—digestive system—malaria	0.0231	0.0809	CbGeAlD
Plerixafor—CXCR4—blood—malaria	0.022	0.0771	CbGeAlD
Plerixafor—CXCR4—bone marrow—malaria	0.0213	0.0746	CbGeAlD
Plerixafor—CXCR4—Peptide GPCRs—ACKR1—malaria	0.0182	0.0746	CbGpPWpGaD
Plerixafor—CXCR4—liver—malaria	0.0172	0.0603	CbGeAlD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CD4—malaria	0.0156	0.0639	CbGpPWpGaD
Plerixafor—Induration—Clindamycin—malaria	0.0144	0.0306	CcSEcCtD
Plerixafor—CXCR4—brain—malaria	0.0137	0.0478	CbGeAlD
Plerixafor—CXCR4—Peptide ligand-binding receptors—ACKR1—malaria	0.00857	0.0351	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—KDR—malaria	0.00763	0.0313	CbGpPWpGaD
Plerixafor—Inflammation—Clindamycin—malaria	0.00663	0.0141	CcSEcCtD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—malaria	0.00622	0.0255	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NOS2—malaria	0.00609	0.025	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Pyrimethamine—malaria	0.00596	0.0127	CcSEcCtD
Plerixafor—Immune system disorder—Proguanil—malaria	0.0059	0.0126	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.00575	0.0235	CbGpPWpGaD
Plerixafor—Mental disorder—Proguanil—malaria	0.00573	0.0122	CcSEcCtD
Plerixafor—Erythema—Proguanil—malaria	0.00569	0.0121	CcSEcCtD
Plerixafor—Injection site reaction—Quinidine barbiturate—malaria	0.00566	0.012	CcSEcCtD
Plerixafor—Swelling—Clindamycin—malaria	0.00529	0.0113	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00481	0.0102	CcSEcCtD
Plerixafor—Swelling—Pentoxifylline—malaria	0.00468	0.00995	CcSEcCtD
Plerixafor—Nervous system disorder—Proguanil—malaria	0.00455	0.00968	CcSEcCtD
Plerixafor—Skin disorder—Proguanil—malaria	0.00451	0.00959	CcSEcCtD
Plerixafor—Hypersensitivity—Pyrimethamine—malaria	0.00439	0.00934	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—ACKR1—malaria	0.00438	0.0179	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Quinidine—malaria	0.00418	0.0089	CcSEcCtD
Plerixafor—Orthostatic hypotension—Quinine—malaria	0.00418	0.0089	CcSEcCtD
Plerixafor—Abdominal distension—Clindamycin—malaria	0.00406	0.00864	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Proguanil—malaria	0.00401	0.00852	CcSEcCtD
Plerixafor—Abdominal discomfort—Clindamycin—malaria	0.00387	0.00823	CcSEcCtD
Plerixafor—Gastrointestinal pain—Proguanil—malaria	0.0038	0.00807	CcSEcCtD
Plerixafor—Vomiting—Pyrimethamine—malaria	0.00379	0.00806	CcSEcCtD
Plerixafor—Orthostatic hypotension—Quinidine barbiturate—malaria	0.00378	0.00803	CcSEcCtD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CD4—malaria	0.00372	0.0152	CbGpPWpGaD
Plerixafor—Abdominal pain—Proguanil—malaria	0.00367	0.00781	CcSEcCtD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—malaria	0.00364	0.0149	CbGpPWpGaD
Plerixafor—Abdominal distension—Pentoxifylline—malaria	0.00359	0.00764	CcSEcCtD
Plerixafor—Abdominal discomfort—Pentoxifylline—malaria	0.00342	0.00727	CcSEcCtD
Plerixafor—Arthralgia—Sulfadiazine—malaria	0.00322	0.00684	CcSEcCtD
Plerixafor—Haemoglobin—Quinidine—malaria	0.00319	0.00677	CcSEcCtD
Plerixafor—Haemoglobin—Quinine—malaria	0.00319	0.00677	CcSEcCtD
Plerixafor—Diarrhoea—Proguanil—malaria	0.00318	0.00676	CcSEcCtD
Plerixafor—Haemorrhage—Quinidine—malaria	0.00317	0.00674	CcSEcCtD
Plerixafor—Haemorrhage—Quinine—malaria	0.00317	0.00674	CcSEcCtD
Plerixafor—Anaphylactic shock—Sulfadiazine—malaria	0.00308	0.00655	CcSEcCtD
Plerixafor—Vomiting—Proguanil—malaria	0.00295	0.00628	CcSEcCtD
Plerixafor—Rash—Proguanil—malaria	0.00293	0.00623	CcSEcCtD
Plerixafor—Dermatitis—Proguanil—malaria	0.00292	0.00622	CcSEcCtD
Plerixafor—Headache—Proguanil—malaria	0.00291	0.00619	CcSEcCtD
Plerixafor—Erythema—Dapsone—malaria	0.00291	0.00618	CcSEcCtD
Plerixafor—Haemoglobin—Quinidine barbiturate—malaria	0.00287	0.00611	CcSEcCtD
Plerixafor—Haemoglobin—Pentoxifylline—malaria	0.00287	0.0061	CcSEcCtD
Plerixafor—Immune system disorder—Quinidine—malaria	0.00286	0.00609	CcSEcCtD
Plerixafor—Immune system disorder—Quinine—malaria	0.00286	0.00609	CcSEcCtD
Plerixafor—Haemorrhage—Quinidine barbiturate—malaria	0.00286	0.00608	CcSEcCtD
Plerixafor—Haemorrhage—Pentoxifylline—malaria	0.00285	0.00607	CcSEcCtD
Plerixafor—Erythema—Clindamycin—malaria	0.00281	0.00598	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00281	0.00597	CcSEcCtD
Plerixafor—Insomnia—Sulfadiazine—malaria	0.00279	0.00593	CcSEcCtD
Plerixafor—Mental disorder—Quinine—malaria	0.00278	0.0059	CcSEcCtD
Plerixafor—Mental disorder—Quinidine—malaria	0.00278	0.0059	CcSEcCtD
Plerixafor—Flatulence—Clindamycin—malaria	0.00277	0.00589	CcSEcCtD
Plerixafor—Erythema—Quinidine—malaria	0.00276	0.00587	CcSEcCtD
Plerixafor—Erythema—Quinine—malaria	0.00276	0.00587	CcSEcCtD
Plerixafor—Nausea—Proguanil—malaria	0.00276	0.00586	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Sulfadiazine—malaria	0.00266	0.00566	CcSEcCtD
Plerixafor—Immune system disorder—Quinidine barbiturate—malaria	0.00258	0.00549	CcSEcCtD
Plerixafor—Immune system disorder—Pentoxifylline—malaria	0.00258	0.00548	CcSEcCtD
Plerixafor—CXCR4—HIV Life Cycle—CD4—malaria	0.00253	0.0104	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Sulfadiazine—malaria	0.00252	0.00536	CcSEcCtD
Plerixafor—Mental disorder—Quinidine barbiturate—malaria	0.00251	0.00533	CcSEcCtD
Plerixafor—Erythema—Quinidine barbiturate—malaria	0.00249	0.00529	CcSEcCtD
Plerixafor—Erythema—Pentoxifylline—malaria	0.00249	0.00528	CcSEcCtD
Plerixafor—Syncope—Quinine—malaria	0.00247	0.00526	CcSEcCtD
Plerixafor—Syncope—Quinidine—malaria	0.00247	0.00526	CcSEcCtD
Plerixafor—Flatulence—Pentoxifylline—malaria	0.00245	0.00521	CcSEcCtD
Plerixafor—Urticaria—Sulfadiazine—malaria	0.00245	0.00521	CcSEcCtD
Plerixafor—Abdominal pain—Sulfadiazine—malaria	0.00244	0.00518	CcSEcCtD
Plerixafor—Loss of consciousness—Quinidine—malaria	0.00242	0.00516	CcSEcCtD
Plerixafor—Loss of consciousness—Quinine—malaria	0.00242	0.00516	CcSEcCtD
Plerixafor—Discomfort—Clindamycin—malaria	0.00237	0.00503	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00233	0.00496	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00233	0.00496	CcSEcCtD
Plerixafor—Ill-defined disorder—Pentoxifylline—malaria	0.00231	0.0049	CcSEcCtD
Plerixafor—Anaphylactic shock—Clindamycin—malaria	0.0023	0.00488	CcSEcCtD
Plerixafor—Hypersensitivity—Sulfadiazine—malaria	0.00227	0.00483	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ACKR1—malaria	0.00225	0.0092	CbGpPWpGaD
Plerixafor—Malaise—Pentoxifylline—malaria	0.00224	0.00477	CcSEcCtD
Plerixafor—Syncope—Quinidine barbiturate—malaria	0.00223	0.00475	CcSEcCtD
Plerixafor—Shock—Quinidine—malaria	0.00222	0.00471	CcSEcCtD
Plerixafor—Shock—Quinine—malaria	0.00222	0.00471	CcSEcCtD
Plerixafor—Nervous system disorder—Quinine—malaria	0.00221	0.0047	CcSEcCtD
Plerixafor—Nervous system disorder—Quinidine—malaria	0.00221	0.0047	CcSEcCtD
Plerixafor—Loss of consciousness—Quinidine barbiturate—malaria	0.00219	0.00465	CcSEcCtD
Plerixafor—Skin disorder—Quinine—malaria	0.00219	0.00465	CcSEcCtD
Plerixafor—Skin disorder—Quinidine—malaria	0.00219	0.00465	CcSEcCtD
Plerixafor—Pruritus—Sulfadiazine—malaria	0.00218	0.00464	CcSEcCtD
Plerixafor—Hyperhidrosis—Quinidine—malaria	0.00218	0.00463	CcSEcCtD
Plerixafor—Hyperhidrosis—Quinine—malaria	0.00218	0.00463	CcSEcCtD
Plerixafor—Insomnia—Dapsone—malaria	0.00215	0.00456	CcSEcCtD
Plerixafor—Arthralgia—Quinidine barbiturate—malaria	0.00212	0.00451	CcSEcCtD
Plerixafor—Diarrhoea—Sulfadiazine—malaria	0.00211	0.00448	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00211	0.00448	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.0021	0.00447	CcSEcCtD
Plerixafor—Discomfort—Pentoxifylline—malaria	0.00209	0.00445	CcSEcCtD
Plerixafor—Dry mouth—Pentoxifylline—malaria	0.00207	0.0044	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Quinine—malaria	0.00205	0.00436	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Quinidine—malaria	0.00205	0.00436	CcSEcCtD
Plerixafor—Dyspnoea—Clindamycin—malaria	0.00205	0.00435	CcSEcCtD
Plerixafor—Anaphylactic shock—Pentoxifylline—malaria	0.00203	0.00431	CcSEcCtD
Plerixafor—Dyspepsia—Clindamycin—malaria	0.00202	0.0043	CcSEcCtD
Plerixafor—Dyspnoea—Quinine—malaria	0.00201	0.00427	CcSEcCtD
Plerixafor—Dyspnoea—Quinidine—malaria	0.00201	0.00427	CcSEcCtD
Plerixafor—Shock—Quinidine barbiturate—malaria	0.002	0.00425	CcSEcCtD
Plerixafor—Shock—Pentoxifylline—malaria	0.002	0.00424	CcSEcCtD
Plerixafor—Nervous system disorder—Quinidine barbiturate—malaria	0.00199	0.00424	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Clindamycin—malaria	0.00198	0.00421	CcSEcCtD
Plerixafor—Fatigue—Clindamycin—malaria	0.00198	0.00421	CcSEcCtD
Plerixafor—Skin disorder—Quinidine barbiturate—malaria	0.00197	0.0042	CcSEcCtD
Plerixafor—Skin disorder—Pentoxifylline—malaria	0.00197	0.00419	CcSEcCtD
Plerixafor—Hyperhidrosis—Quinidine barbiturate—malaria	0.00196	0.00418	CcSEcCtD
Plerixafor—Constipation—Clindamycin—malaria	0.00196	0.00417	CcSEcCtD
Plerixafor—Pain—Clindamycin—malaria	0.00196	0.00417	CcSEcCtD
Plerixafor—Hyperhidrosis—Pentoxifylline—malaria	0.00196	0.00417	CcSEcCtD
Plerixafor—Vomiting—Sulfadiazine—malaria	0.00196	0.00417	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Quinine—malaria	0.00194	0.00413	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Quinidine—malaria	0.00194	0.00413	CcSEcCtD
Plerixafor—Rash—Sulfadiazine—malaria	0.00194	0.00413	CcSEcCtD
Plerixafor—Dermatitis—Sulfadiazine—malaria	0.00194	0.00413	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dapsone—malaria	0.00194	0.00413	CcSEcCtD
Plerixafor—Headache—Sulfadiazine—malaria	0.00193	0.00411	CcSEcCtD
Plerixafor—Gastrointestinal pain—Clindamycin—malaria	0.00188	0.00399	CcSEcCtD
Plerixafor—Abdominal pain—Dapsone—malaria	0.00188	0.00399	CcSEcCtD
Plerixafor—Feeling abnormal—Quinine—malaria	0.00186	0.00395	CcSEcCtD
Plerixafor—Feeling abnormal—Quinidine—malaria	0.00186	0.00395	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00185	0.00394	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00185	0.00393	CcSEcCtD
Plerixafor—Gastrointestinal pain—Quinine—malaria	0.00184	0.00392	CcSEcCtD
Plerixafor—Gastrointestinal pain—Quinidine—malaria	0.00184	0.00392	CcSEcCtD
Plerixafor—Insomnia—Pentoxifylline—malaria	0.00183	0.0039	CcSEcCtD
Plerixafor—Nausea—Sulfadiazine—malaria	0.00183	0.00389	CcSEcCtD
Plerixafor—Urticaria—Clindamycin—malaria	0.00182	0.00388	CcSEcCtD
Plerixafor—Abdominal pain—Clindamycin—malaria	0.00181	0.00386	CcSEcCtD
Plerixafor—Dyspnoea—Quinidine barbiturate—malaria	0.00181	0.00385	CcSEcCtD
Plerixafor—Dyspnoea—Pentoxifylline—malaria	0.00181	0.00385	CcSEcCtD
Plerixafor—CXCR4—Disease—PKLR—malaria	0.0018	0.00736	CbGpPWpGaD
Plerixafor—Urticaria—Quinine—malaria	0.00179	0.0038	CcSEcCtD
Plerixafor—Urticaria—Quinidine—malaria	0.00179	0.0038	CcSEcCtD
Plerixafor—Dyspepsia—Pentoxifylline—malaria	0.00179	0.0038	CcSEcCtD
Plerixafor—Abdominal pain—Quinine—malaria	0.00178	0.00378	CcSEcCtD
Plerixafor—Abdominal pain—Quinidine—malaria	0.00178	0.00378	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00175	0.00373	CcSEcCtD
Plerixafor—CXCR4—HIV Infection—CD4—malaria	0.00175	0.00716	CbGpPWpGaD
Plerixafor—Pain—Quinidine barbiturate—malaria	0.00174	0.0037	CcSEcCtD
Plerixafor—Constipation—Quinidine barbiturate—malaria	0.00174	0.0037	CcSEcCtD
Plerixafor—Constipation—Pentoxifylline—malaria	0.00173	0.00369	CcSEcCtD
Plerixafor—Hypersensitivity—Clindamycin—malaria	0.00169	0.0036	CcSEcCtD
Plerixafor—Feeling abnormal—Quinidine barbiturate—malaria	0.00167	0.00356	CcSEcCtD
Plerixafor—Feeling abnormal—Pentoxifylline—malaria	0.00167	0.00355	CcSEcCtD
Plerixafor—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00166	0.00353	CcSEcCtD
Plerixafor—Hypersensitivity—Quinine—malaria	0.00166	0.00353	CcSEcCtD
Plerixafor—Hypersensitivity—Quinidine—malaria	0.00166	0.00353	CcSEcCtD
Plerixafor—Gastrointestinal pain—Pentoxifylline—malaria	0.00166	0.00353	CcSEcCtD
Plerixafor—Asthenia—Clindamycin—malaria	0.00165	0.0035	CcSEcCtD
Plerixafor—Pruritus—Clindamycin—malaria	0.00162	0.00345	CcSEcCtD
Plerixafor—Asthenia—Quinine—malaria	0.00162	0.00344	CcSEcCtD
Plerixafor—Asthenia—Quinidine—malaria	0.00162	0.00344	CcSEcCtD
Plerixafor—Urticaria—Quinidine barbiturate—malaria	0.00161	0.00343	CcSEcCtD
Plerixafor—Urticaria—Pentoxifylline—malaria	0.00161	0.00343	CcSEcCtD
Plerixafor—Abdominal pain—Quinidine barbiturate—malaria	0.00161	0.00342	CcSEcCtD
Plerixafor—Abdominal pain—Pentoxifylline—malaria	0.0016	0.00341	CcSEcCtD
Plerixafor—CXCR4—Disease—G6PD—malaria	0.0016	0.00656	CbGpPWpGaD
Plerixafor—Pruritus—Quinidine—malaria	0.00159	0.00339	CcSEcCtD
Plerixafor—Pruritus—Quinine—malaria	0.00159	0.00339	CcSEcCtD
Plerixafor—Diarrhoea—Clindamycin—malaria	0.00157	0.00334	CcSEcCtD
Plerixafor—Diarrhoea—Quinidine—malaria	0.00154	0.00328	CcSEcCtD
Plerixafor—Diarrhoea—Quinine—malaria	0.00154	0.00328	CcSEcCtD
Plerixafor—Dizziness—Clindamycin—malaria	0.00152	0.00323	CcSEcCtD
Plerixafor—Vomiting—Dapsone—malaria	0.00151	0.00321	CcSEcCtD
Plerixafor—Hypersensitivity—Quinidine barbiturate—malaria	0.0015	0.00318	CcSEcCtD
Plerixafor—Hypersensitivity—Pentoxifylline—malaria	0.00149	0.00318	CcSEcCtD
Plerixafor—Dizziness—Quinidine—malaria	0.00149	0.00317	CcSEcCtD
Plerixafor—Dizziness—Quinine—malaria	0.00149	0.00317	CcSEcCtD
Plerixafor—Headache—Dapsone—malaria	0.00149	0.00316	CcSEcCtD
Plerixafor—Vomiting—Clindamycin—malaria	0.00146	0.0031	CcSEcCtD
Plerixafor—Asthenia—Quinidine barbiturate—malaria	0.00146	0.0031	CcSEcCtD
Plerixafor—Asthenia—Pentoxifylline—malaria	0.00146	0.00309	CcSEcCtD
Plerixafor—Rash—Clindamycin—malaria	0.00145	0.00308	CcSEcCtD
Plerixafor—Dermatitis—Clindamycin—malaria	0.00145	0.00307	CcSEcCtD
Plerixafor—Headache—Clindamycin—malaria	0.00144	0.00306	CcSEcCtD
Plerixafor—Pruritus—Quinidine barbiturate—malaria	0.00144	0.00306	CcSEcCtD
Plerixafor—Pruritus—Pentoxifylline—malaria	0.00144	0.00305	CcSEcCtD
Plerixafor—Vomiting—Quinidine—malaria	0.00143	0.00304	CcSEcCtD
Plerixafor—Vomiting—Quinine—malaria	0.00143	0.00304	CcSEcCtD
Plerixafor—Rash—Quinine—malaria	0.00142	0.00302	CcSEcCtD
Plerixafor—Rash—Quinidine—malaria	0.00142	0.00302	CcSEcCtD
Plerixafor—Dermatitis—Quinidine—malaria	0.00142	0.00302	CcSEcCtD
Plerixafor—Dermatitis—Quinine—malaria	0.00142	0.00302	CcSEcCtD
Plerixafor—Headache—Quinidine—malaria	0.00141	0.003	CcSEcCtD
Plerixafor—Headache—Quinine—malaria	0.00141	0.003	CcSEcCtD
Plerixafor—Nausea—Dapsone—malaria	0.00141	0.003	CcSEcCtD
Plerixafor—Diarrhoea—Quinidine barbiturate—malaria	0.00139	0.00296	CcSEcCtD
Plerixafor—Diarrhoea—Pentoxifylline—malaria	0.00139	0.00295	CcSEcCtD
Plerixafor—Nausea—Clindamycin—malaria	0.00136	0.0029	CcSEcCtD
Plerixafor—Dizziness—Quinidine barbiturate—malaria	0.00134	0.00286	CcSEcCtD
Plerixafor—Dizziness—Pentoxifylline—malaria	0.00134	0.00285	CcSEcCtD
Plerixafor—Nausea—Quinidine—malaria	0.00134	0.00284	CcSEcCtD
Plerixafor—Nausea—Quinine—malaria	0.00134	0.00284	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ACKR1—malaria	0.00133	0.00543	CbGpPWpGaD
Plerixafor—Vomiting—Quinidine barbiturate—malaria	0.00129	0.00275	CcSEcCtD
Plerixafor—Vomiting—Pentoxifylline—malaria	0.00129	0.00274	CcSEcCtD
Plerixafor—Rash—Quinidine barbiturate—malaria	0.00128	0.00272	CcSEcCtD
Plerixafor—Dermatitis—Quinidine barbiturate—malaria	0.00128	0.00272	CcSEcCtD
Plerixafor—Rash—Pentoxifylline—malaria	0.00128	0.00272	CcSEcCtD
Plerixafor—Dermatitis—Pentoxifylline—malaria	0.00128	0.00272	CcSEcCtD
Plerixafor—Headache—Quinidine barbiturate—malaria	0.00127	0.00271	CcSEcCtD
Plerixafor—Headache—Pentoxifylline—malaria	0.00127	0.0027	CcSEcCtD
Plerixafor—Nausea—Quinidine barbiturate—malaria	0.00121	0.00257	CcSEcCtD
Plerixafor—Nausea—Pentoxifylline—malaria	0.0012	0.00256	CcSEcCtD
Plerixafor—CXCR4—Disease—DHFR—malaria	0.00113	0.00464	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TLR9—malaria	0.00107	0.00438	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—malaria	0.000578	0.00237	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—malaria	0.000514	0.00211	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—malaria	0.000467	0.00191	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD4—malaria	0.000428	0.00175	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KDR—malaria	0.000426	0.00174	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—malaria	0.000276	0.00113	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—malaria	0.000275	0.00112	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—malaria	0.000232	0.000949	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—malaria	0.000162	0.000664	CbGpPWpGaD
